Unilever Signals Pursuit Of GSK Consumer Arm; Shares Fall
(Reuters) -Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline’s consumer health business, calling it a “strong strategic fit” after its 50-billion-pound ($68.4 billion) offer was rejected, sending its shares down 6%. GSK confirmed over the weekend that it had rejected the Dove soap maker’s bid for its consumer healthcare business, which is…
